Teleflex shares rise on Q2 beat and raise

Share

TeleflexShares in Teleflex (NYSE:TFX) rose today after the medical device maker topped expectations on Wall Street with its 2nd quarter earnings results, providing lifted guidance for the rest of its fiscal year.

The Wayne, Pa.-based company posted profits of $78 million, or $1.67 per share, on sales of $528.6 million for the 3 months ended June 30, for bottom-line growth of 30.9% while sales grew 11.4% compared with the same period last year.

Read the whole story on our sister site, MassDevice.com

How do you know your technology is disruptive enough to break conventional wisdom?

textadimage Stan Rowe knows a little something about bringing disruptive technology to market. The current Edwards Lifesciences CSO was in on the ground floor of two of medtech's most disruptive treatments, stents and transcatheter aortic valve replacement.

On December 12th, Rowe will sit down with MassDevice editor Brad Perriello for a long ranging discussion about the inside story on how these technologies came to market and what Rowe learned along the way.


Register now with the code "TAVR" and save 15% today.

Speak Your Mind

*